Article Details

New acquisition is key for Think Research, says Desjardins - Cantech Letter

Retrieved on: 2021-09-20 16:07:30

Tags for this article:

Click the tags to see associated articles and topics

New acquisition is key for Think Research, says Desjardins - Cantech Letter. View article details on hiswai:

Excerpt

“It should reach $3 million in run-rate synergies six months after closing, bringing BioPharma's EBITDA margin to approximately 20 per cent from approximately ...

Article found on: www.cantechletter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up